Viewing Study NCT00085358

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-05-27 @ 2:02 AM
Study NCT ID: NCT00085358
Status: COMPLETED
Last Update Posted: 2019-07-22
First Post: 2004-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brenner Tumor View
None Fallopian Tube Cancer View
None Ovarian Carcinosarcoma View
None Ovarian Clear Cell Cystadenocarcinoma View
None Ovarian Endometrioid Adenocarcinoma View
None Ovarian Mixed Epithelial Carcinoma View
None Ovarian Mucinous Cystadenocarcinoma View
None Ovarian Serous Cystadenocarcinoma View
None Ovarian Undifferentiated Adenocarcinoma View
None Primary Peritoneal Cavity Cancer View
None Stage II Ovarian Epithelial Cancer View
None Stage III Ovarian Epithelial Cancer View
None Stage IV Ovarian Epithelial Cancer View
Keywords: